Instability in short-run adjustments to purchasing power parity: results for selected Latin American countries

1995 ◽  
Vol 27 (10) ◽  
pp. 973-983 ◽  
Author(s):  
Peter C. Liu ◽  
Paul Burkett
Keyword(s):  
Latin American ◽  
Purchasing Power Parity ◽  
Purchasing Power ◽  
Power Parity ◽  
Short Run ◽  
Latin American Countries

scholarly journals Purchasing Power Parity Principle in Latin American Countries

2018 ◽  
Vol 13 (3) ◽  
pp. 461-477
Author(s):  
Domingo Rodríguez-Benavides ◽  
◽  
José Antonio Climent-Hernández ◽  
Luis Fernando Hoyos-Reyes
Keyword(s):  
Latin American ◽  
Purchasing Power Parity ◽  
Purchasing Power ◽  
Power Parity ◽  
Parity Principle ◽  
Latin American Countries

scholarly journals Availability of biological cancer drugs under research: registration and price in Brazil, Colombia, and Mexico

2020 ◽  
Vol 30 (4) ◽  
Author(s):  
Gabriela Bittencourt Gonzalez Mosegui ◽  
Fernando Antõnanzas Villar
Keyword(s):  
Latin American ◽  
Purchasing Power Parity ◽  
The United States ◽  
Cancer Drug ◽  
Regulatory Agencies ◽  
Purchasing Power ◽  
Power Parity ◽  
Drug Access ◽  
The Usa ◽  
Latin American Countries

Abstract This study seeks to understand biological cancer drug availability through registration and prices of the biological agents used for cancer therapy and authorized for sale in the last 5 years in Brazil, Colombia, and Mexico, comparing the data to those for the United States of America (USA) and Spain. The regulatory agencies’ websites were assessed for drugs registered between January 1, 2014, and February 20, 2019. Drug prices were sought in the clerical databases. Prices were also compared using purchasing power parity (PPP). The comparison between the purchasing power (PP) of the three Latin American countries is hampered by market heterogeneity and uncertainty in the data. There is no registration synchronization. The average difference between the launch time in the USA and in the other countries is 1.6 to 2.6 years. The USA has the lowest PPP values, compared to the Latin American countries studied, but higher prices. Differences in registration time reveal issues in drug access in the Latin American countries studied or a lack of equity between countries. The economic effort that these countries make to have access to these supplies is much higher than that of the USA and Spain.

scholarly journals Purchasing Power Parity Principle in Latin American Countries

2018 ◽  
Vol 13 (3) ◽  
pp. 461-477
Author(s):  
Domingo Rodríguez-Benavides ◽  
◽  
José Antonio Climent-Hernández ◽  
Luis Fernando Hoyos-Reyes
Keyword(s):  
Latin American ◽  
Purchasing Power Parity ◽  
Purchasing Power ◽  
Power Parity ◽  
Parity Principle ◽  
Latin American Countries

scholarly journals On the Purchasing Power Parity for Latin-American Countries

2009 ◽  
Vol 12 (1) ◽  
pp. 33-54 ◽  
Author(s):  
Jose Angelo Divino ◽  
Vladimir Kuhl Teles ◽  
Joaquim Pinto de Andrade
Keyword(s):  
Latin American ◽  
Purchasing Power Parity ◽  
Purchasing Power ◽  
Power Parity ◽  
Latin American Countries

Revisiting purchasing power parity for 16 Latin American countries: panel SURADF tests

2011 ◽  
Vol 18 (3) ◽  
pp. 251-255 ◽  
Author(s):  
Yang-Cheng Ralph Lu ◽  
Tsangyao Chang ◽  
Chi-Chen Chiu ◽  
Han-Wen Tzeng
Keyword(s):  
Latin American ◽  
Purchasing Power Parity ◽  
Purchasing Power ◽  
Power Parity ◽  
Latin American Countries
Sign in / Sign up

Export Citation Format

Share Document